Evaluación del impacto epidemiológico y económico de las vacunas para COVID-19 según comorbilidad y nivel socioeconómico en el País Vasco

Reference: BIO21/COV/001
Coordinator: Biodonostia Health Research Institute
Partners: BCAM - Basque Center for Applied Mathematics
Duration: 2021 - 2023
Funding agency: Basque Government (BIOEF - Proyectos de investigación en COVID-19)
Tipo: Regional Project
Estado: Ongoing Project

Objective:

Four COVID-19 vaccines are currently on the market (P zer / BioNTech, Moderna, Oxford-Astrazeneca and Janssen). It is necessary to assess the epidemiological and economic impact of the vaccination process. This requires the use of dynamic models that take into account the herd e ect. Comorbidity and socioeconomic status are associated with the risks associated with COVID-19 infection. The objective of this project is to carry out an evaluation of the epidemiological and economic impact of the vaccination program for COVID-19 in Osakidetza according to comorbidity and socioeconomic level.